The management of recurrent ovarian cancer
- PMID: 17512352
- DOI: 10.1053/j.seminoncol.2007.03.012
The management of recurrent ovarian cancer
Similar articles
-
Ovarian cancer: a focus on management of recurrent disease.Nat Clin Pract Oncol. 2006 Nov;3(11):604-11. doi: 10.1038/ncponc0637. Nat Clin Pract Oncol. 2006. PMID: 17080178 Review.
-
[Decision-making of treatment and relative problems about recurrent and drug-resistant gynecologic neoplasms].Zhonghua Fu Chan Ke Za Zhi. 2010 Nov;45(11):801-3. Zhonghua Fu Chan Ke Za Zhi. 2010. PMID: 21211274 Chinese. No abstract available.
-
[Therapy for ovarian cancer--general review].Nihon Rinsho. 2004 Oct;62 Suppl 10:517-21. Nihon Rinsho. 2004. PMID: 15535299 Review. Japanese. No abstract available.
-
New developments in the management of ovarian cancer.J Med Assoc Ga. 2003 Winter-Spring;92(1):23-6, 33. J Med Assoc Ga. 2003. PMID: 12743902 Review. No abstract available.
-
Ovarian cancer.J Indian Med Assoc. 2012 Dec;110(12):894-7. J Indian Med Assoc. 2012. PMID: 23936953 No abstract available.
Cited by
-
Trabectedin : a review of its use in the management of soft tissue sarcoma and ovarian cancer.Drugs. 2007;67(15):2257-76. doi: 10.2165/00003495-200767150-00009. Drugs. 2007. PMID: 17927287 Review.
-
IGF1R inhibition and PD-1 blockade improve anti-tumor immune response in epithelial ovarian cancer.Front Oncol. 2024 Oct 10;14:1410447. doi: 10.3389/fonc.2024.1410447. eCollection 2024. Front Oncol. 2024. PMID: 39450263 Free PMC article.
-
High-grade serous ovarian cancer arises from fallopian tube in a mouse model.Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3921-6. doi: 10.1073/pnas.1117135109. Epub 2012 Feb 13. Proc Natl Acad Sci U S A. 2012. PMID: 22331912 Free PMC article.
-
Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model.Eur J Nucl Med Mol Imaging. 2014 Oct;41(10):1907-15. doi: 10.1007/s00259-014-2798-3. Epub 2014 May 24. Eur J Nucl Med Mol Imaging. 2014. PMID: 24859811
-
Genomic and Epigenomic Signatures in Ovarian Cancer Associated with Resensitization to Platinum Drugs.Cancer Res. 2018 Feb 1;78(3):631-644. doi: 10.1158/0008-5472.CAN-17-1492. Epub 2017 Dec 11. Cancer Res. 2018. PMID: 29229600 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical